SINGAPORE - Biosensors International Group said it had been informed by major shareholder, Citic Private Equity Funds Management Co, that it has undertaken certain steps to restructure its shareholding interests in the mainboard-listed company.

Citic said it is still considering the options available to it to enhance the value of its investment in Biosensors and that no decision has been made at this juncture.

Bionsensors put out this statement in additonal response to queries on the trading activity of its shares, which fell sharply last week on news that Citic, through CB Medical Holdings, sold off about 39.5 million units at an average price of 84 US cents per share.